Jenoptik Balance Sheet Health

Financial Health criteria checks 4/6

Jenoptik has a total shareholder equity of €939.5M and total debt of €480.1M, which brings its debt-to-equity ratio to 51.1%. Its total assets and total liabilities are €1.7B and €741.3M respectively. Jenoptik's EBIT is €159.1M making its interest coverage ratio 7.4. It has cash and short-term investments of €58.7M.

Key information

51.1%

Debt to equity ratio

€480.11m

Debt

Interest coverage ratio7.4x
Cash€58.73m
Equity€939.53m
Total liabilities€741.33m
Total assets€1.68b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: JEN's short term assets (€581.7M) exceed its short term liabilities (€254.3M).

Long Term Liabilities: JEN's short term assets (€581.7M) exceed its long term liabilities (€487.0M).


Debt to Equity History and Analysis

Debt Level: JEN's net debt to equity ratio (44.9%) is considered high.

Reducing Debt: JEN's debt to equity ratio has increased from 15.8% to 51.1% over the past 5 years.

Debt Coverage: JEN's debt is well covered by operating cash flow (39.6%).

Interest Coverage: JEN's interest payments on its debt are well covered by EBIT (7.4x coverage).


Balance Sheet


Discover healthy companies